Abstract
Developing an appropriate animal model that could simulate clinical bacterial meningitis 61 in newborn infants would be essential to determine its pathogenesis, and also to test the 62 efficacy of newly developed adjuvant treatments in addition to the use of antibiotics.
63
Currently, several animal models of neonatal bacterial meningitis, including newborn piglets 64 (4), mice (5-7), rats (8, 9), or rabbits(10) are available, and meningitis was induced by various 65 routes including intraperitoneal (5, 11), intranasal (6), intravenous (5, 10, 12), or 66 intracisternal (7-10, 12) inoculation of bacteria. However, these animal models have certain 67 drawbacks, including small sample size, low infectivity, high mortality, and/or variable 68 extent of brain injury (11). Furthermore, concomitant bacteremia might aggravate the 69 meningitis-induced brain injury (9, 13, 14), thus increasing mortality (8, 9, 15). Therefore, in 70 the present study, we developed a newborn rat model of neonatal bacterial meningitis to 71 mimic the human clinical and neuropathological abnormalities, using 11-day-old newborn 
MATERIALS AND METHODS

83
Infecting organism 84 We used EC5ME, an un-encapsulated mutant of E. coli strain possessing the K1 capsular 85 polysaccharide C5 (serotype 018:K1:H7) (a kind gift from Professor Kwang Sik Kim, Johns
86
Hopkins University, MD, USA)(12, 16) to induce only bacterial meningitis, but not 87 secondary bacteremia, in this study. Bacteria were cultured overnight in brain heart infusion 88 broth, diluted in fresh medium, and grown for another 6 h to mid-logarithmic phase. The 89 culture was centrifuged at 5,000 ×g for 10 min, re-suspended in sterile normal saline to the 90 desired concentration, and used for intraventricular injection. The accuracy of the inoculum The experiment began at P11, and continued through to P17. We assessed and monitored the 102 condition of rat pups on a daily basis regularly. To induce meningitis, newborn Sprague-
103
Dawley rats (Orient Co, Seoul, Korea) were anesthetized using 2% isoflurane in oxygen 104 enriched air, and a total of 10 µl EC5ME inoculum in saline was slowly infused into the left MyNeurolab, St. Louis, MO, USA; coordinates: x = ± 0.5, y = ± 1.0, z = ± 2.5 mm relative to 107 the bregma) at P11. To determine the optimal inoculum dose with minimal mortality and 108 maximal brain injury, we tested three different inoculum doses of E. coli: A low inoculum 109 dose of 1 × 10 2 CFU EC5ME (LE), a medium inoculum dose of 5 × 10 2 CFU EC5ME (ME),
110
and a high inoculum dose of 1 × 10 3 CFU EC5ME (HE). For normal control group (NC), 111 equal volume of normal saline was given intraventricularly. After the procedure, the rat pups 112 were allowed to recover and returned to their dams, and there was no mortality associated 113 with the procedure. First, 10 rat pups for each group were allocated to assess the acute 114 pathophysiological changes, and the survivors were sacrificed at 24 h (P12) after bacterial 115 inoculation for histopathological assessment (n = 6, 5, 4 and 3 for the NC, LE, ME and HE 116 groups, respectively) and biochemical analyses (n = 4, 4, 4 and 3 for the NC, LE, ME and HE 117 groups, respectively). We also conducted the time course experiment in 10 animals for each 118 group to determine the survival rate until sacrifice of the survivors at P17 for histopathological assessment (n = 5, 4, 4 and 2 for the NC, LE, ME and HE groups, 120 respectively) and biochemical analyses (n = 5, 3, 4 and 0 for the NC, LE, ME and HE groups, 
Bacterial quantification
137
Bacterial concentrations from each study group were measured in the CSF and blood at 6 h, The brain MRI was performed while the rats were kept in an anesthetized state by the 144 administration of 1.5-2% isoflurane in oxygen-enriched air using a facemask. All MRI 145 examinations were performed using a 7.0-tesla MRI System (Bruker-Biospin, Fällanden,
146
Switzerland) prepared with a 20-cm gradient set capable of providing a rising time of 400 147 mTm-1. The MR images were acquired with 1.0-mm slice thickness, and a total of 12 slices 148 were acquired. Brain MRI was performed at P12 (n = 10, 9, 8 and 6 in the NC, LE, ME and 149 HE groups, respectively) and at P17 (n = 11, 7, 8 and 2 in the NC, LE, ME and HE groups, 150 respectively). After the MRI exams, the rat pups were allowed to recover and were returned 151 to their dams.
153
Measurement of the extent of brain injury by MRI
154
All MR images were analyzed using Image J software (National Institutes of Health). The 
Tissue preparation
161
Brain tissue preparation procedures were performed in the surviving animals until P12 (n = 162 10, 9, 8 and 6 in the NC, LE, ME and HE groups, respectively) and P17 (n = 10, 7, 8 and 2 in 163 the NC, LE, ME and HE groups, respectively). The animals were anesthetized with sodium 164 pentobarbital (100 mg/kg), and their brains were isolated after thoracotomy and transcardiac 165 perfusion with ice-cold 4% paraformaldehyde in 0.1 mol/l phosphate-buffered saline (PBS).
166
The brains were carefully removed from the animals and fixed overnight with 4% and reactive microglia (ED-1) was performed on deparaffinized 4-μm thick brain sections.
186
The slices were incubated with the primary anti-GFAP antibodies (rabbit polyclonal; Dako,
187
Glostrup, Denmark, overnight, 4 C, 1:1,000 in PBS with 1% bovine serum albumin) and the 188 anti-ED-1 antibodies (mouse polyclonal; Millipore, CA, USA, overnight, 4 C, 1:500 in PBS 189 with 1% bovine serum albumin). After three rinses (same buffer), the sections were incubated (colony forming unit) EC5ME (LE), a medium inoculum dose of 5 × 102 CFU EC5ME 217 (ME), and a high inoculum dose of 1 × 103 CFU EC5ME (HE). The survival rate after 218 induction of bacterial meningitis was bacterial inoculum dose-dependent, showing the lowest 219 survival rate up to postnatal day (P)17 of 20% for the high inoculum dose (HE), and 70% and 220 80% for LE and ME doses, respectively (Fig 2A) . While survival rate up to P17 in the HE 221 group was significantly lower compared to that in the no inoculum control (NC), the survival 222 rate of the LE and ME groups was not significantly reduced compared with the NC group.
223
While birth body and brain weight in each study group was not significantly different 224 between the study groups; the body weight gain at P17 in the LE, ME, and HE groups was 225 significantly lower, the brain weight gain in the ME and HE groups was significantly lower,
226
and the brain/body weight ratio in the ME and HE groups was significantly higher compared 227 with the those in the NC group. The least body and brain weight gain, and the highest 228 brain/body ratio, were observed in the HE group compared with those in the LE and ME 229 groups (Fig 2B-D) . analysis followed by a log-rank test. LE, low dose E. coli group; ME, medium dose E. coli are presented as the mean ± standard error of the mean (SEM). * P < 0.05 compared with the 238 NC group, # P < 0.05 compared with the LE group, $ P < 0.05 compared with the ME group.
240
Bacterial counts
241
To evaluate the bacterial burdens, the CFU were counted in the cerebrospinal fluid (CSF) 242 and blood from each study groups at 6 h (P11), 24 h (P12), and 6 days (P17) after induction 243 of meningitis. While no bacterial growth in the blood was detected in all study groups 244 throughout the experiment, the bacterial counts in the CSF at 6 h after the induction of 245 meningitis in both the LE and ME were significantly lower compare with that in the HE.
246
Thereafter, the bacterial counts in the CSF of all study groups increased significantly 247 compared with that at 6 h, and there were no significant inter-group differences at 24 h after 248 the induction of meningitis (Fig 3) . No bacterial growth in the CSF was detected all study 249 groups at 6 days after the induction of meningitis. 
263
The brain infarct volume ratios at P12 and P17 were bacterial inoculum dose-dependently 264 increased, showing the highest ratio in the HE group, and a seemingly increased ratio in the 265 ME group compared with that in the LE group that did not reach statistical significance (Fig   266   4) . The ventriculomegaly volume ratios at P12 were bacterial inoculum dose-dependently 267 increased, showing the highest increase in the HE group compared with that in the LE and 268 ME groups. In addition, although the absolute extent of ventriculomegaly was significantly 269 reduced compared with P12, the ventriculomegaly volume ratios at P17 were also bacterial 270 inoculum dose-dependently increased, showing the highest increase in the HE group 271 compared with that in the LE and ME groups (Fig 4) . ventriculomegaly volume ratio were measured by MRI at P12 and P17. LE, low dose E. coli 278 group; ME, medium dose E. coli group; HE, high dose E. coli group. Data are presented as 279 the mean ± SEM. * P < 0.05 compared with the NC group, # P < 0.05 compared with the LE 280 group, $ P < 0.05 compared with the ME group. low dose E. coli group; ME, medium dose E. coli group; HE, high dose E. coli group. Data 301 are presented as the mean ± SEM. * P < 0.05 compared with the NC group, # P < 0.05 302 compared with the LE group, $ P < 0.05 compared with the ME group. HE group. The inflammatory cytokine levels in the ME group were significantly higher 14 309 compared with those in the LE group (Fig 6) . Although the brain homogenates of the HE 310 group were not available for measurements because of their high mortality at P17, and the 311 absolute levels of the inflammatory cytokines were significantly reduced compared with P12, 312 the inflammatory cytokines were bacterial inoculum dose-dependently increased, showing 313 significantly higher levels in the ME group compared with those in the LE group. were measured using ELISA in each group. LE, low dose E. coli group; ME, medium dose E. 318 coli group; HE, high dose E. coli group. Data are presented as the mean ± SEM. * P < 0.05 319 compared with the NC group, # P < 0.05 compared with the LE group, $ P < 0.05 compared 320 with the ME group. In this study, E. coli was used to induce meningitis, because it is the most frequent for developing E. coli meningitis in rats, we used K1(-) E. coli in this study to prevent 
371
In the present study, we tested three different doses of K1 (-) E. coli (EC5ME) for the 372 induction of meningitis to determine the optimal inoculum dose with minimal mortality and 373 maximal brain injury; 1 × 10 2 CFU for the LE group, 5 × 10 2 CFU for the ME group, and 1 × experiment, the inoculum dose-dependent increase in mortality, inflammatory responses, and 382 brain injury solely reflects the virulence of EC5ME meningitis, without the confounding 383 effects of the concomitant systemic bacteremia. Overall, these findings suggest that ME (5 × 384 10 2 CFU) of EC5ME might be optimal inoculum dose to induce neonatal meningitis.
385
Because bacterial meningitis induces high mortality in newborn infants, the design of 386 animal study was also driven to target for severe, end-stage models. From 
